PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics
dc.contributor.author | McDonagh, Ellen M. | |
dc.contributor.author | Thorn, Caroline F. | |
dc.contributor.author | Callaghan, John Thomas | |
dc.contributor.author | Altman, Russ B. | |
dc.contributor.author | Klein, Teri E. | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2025-04-03T12:42:42Z | |
dc.date.available | 2025-04-03T12:42:42Z | |
dc.date.issued | 2014 | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | McDonagh EM, Thorn CF, Callaghan JT, Altman RB, Klein TE. PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics. Pharmacogenet Genomics. 2014;24(9):464-476. doi:10.1097/FPC.0000000000000058 | |
dc.identifier.uri | https://hdl.handle.net/1805/46792 | |
dc.language.iso | en_US | |
dc.publisher | Wolters Kluwer | |
dc.relation.isversionof | 10.1097/FPC.0000000000000058 | |
dc.relation.journal | Pharmacogenetics and Genomics | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Gene expression regulation | |
dc.subject | Genetic variation | |
dc.subject | Gout suppressants | |
dc.subject | Uric acid | |
dc.title | PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics | |
dc.type | Article |